Argatroban: A Viewpoint by Theodore E. Warkentin

Warkentin, T.E.
February 2001
Drugs;Feb2001, Vol. 61 Issue 4, p523
Academic Journal
Focuses on the effectiveness of argatroban drug in treating thrombosis. Emergence of heparin-induced thrombocytopenia; Benefits of argatroban; Therapeutic options offered by argatroban.


Related Articles

  • Cost-effectiveness of low-molecular-weight heparin and unfractionated heparin in treatment of deep vein thrombosis. Rodger, Marc; Bredeson, Christopher; Wells, Philip S.; Beck, Julie; Kearns, Brenda; Huebsch, Lothar B. // CMAJ: Canadian Medical Association Journal;10/20/98, Vol. 159 Issue 8, p931 

    Presents a study that seeks to determine whether unfractionated heparin or low-molecular-weight heparins was more cost-effective for treatment of deep vein thrombosis. Methods; Results; Interpretation.

  • Drug-eluting stents: a critique. Melikian, N.; Wijns, W . // Heart;Feb2008, Vol. 94 Issue 2, p145 

    Despite advances in the design of balloons and stents, restenosis remains a major drawback of coronary angioplasty. Multiple randomised trials have demonstrated that drug-eluting stents (DES) can significantly reduce rates of restenosis by 60-75% across both lesion and patient subsets. In recent...

  • Venous Thrombosis Treated with Continuous IV Heparin. Apgar, Barbara // American Family Physician;11/1/1996, Vol. 54 Issue 6, p2106 

    Presents a summary of the article `The relation between the activated partial thromboplastin time response and recurrence in patients with venous thrombosis treated with continuous intravenous heparin,' by S. Anand from `Archives of Internal Medicine' dated 1996. Methods used in the study;...

  • Longer warfarin treatment cuts risk of repeat clots. Basky, Greg // CMAJ: Canadian Medical Association Journal;6/15/99, Vol. 160 Issue 12, p1692 

    Reports the length of treatment of venous thromboembolism with warfarin, according to Canadian research as of June 15, 1999. Details of the study of Dr. Clive Kearon, associate professor of medicine at McMaster University in Hamilton, Ontario; Findings, including the benefits of extended...

  • Bilateral ultrasonography for evaluation of suspected DVT. Apgar, Barbara // American Family Physician;12/1/1996, Vol. 54 Issue 8, p2552 

    Presents a summary of the article `Suspected Deep Venous Thrombosis: Is US of Both Legs Necessary?,' by J.B. Naidich, et al from the journal `Radiology' dated 1996. Methodology of the study; Signs and symptoms of deep venous thrombosis; Outcome of the study; Conclusion.

  • Prevention of Lower Extremity Venous Thrombosis by Early Mobilization. Miller, Richard R.; Lies, James E.; Carretta, Robert F.; Wampold, David B.; DeNardo, Gerald L.; Kraus, Jess F.; Amsterdam, Ezra A.; Mason, Dean T. // Annals of Internal Medicine;Jun76, Vol. 84 Issue 6, p700 

    Presents information on a study that showed that the high frequency of peripheral venous thrombosis in immobilized acute myocardial infarction patients, particularly those with heart failure, can be effectively reduced by early ambulation. Research materials and methods; Results and discussion...

  • Does this patient have deep vein thrombosis? Anand, Sonia S.; Wells, Philip S.; Hunt, Dereck; Brill-Edwards, Pat; Cook, Deborah; Ginsberg, Jeffrey S.; Anand, S S; Wells, P S; Hunt, D; Brill-Edwards, P; Cook, D; Ginsberg, J S // JAMA: Journal of the American Medical Association;4/8/98, Vol. 279 Issue 14, p1094 

    Objective: To review the validity of the clinical assessment and diagnostic tests in patients with suspected deep vein thrombosis (DVT).Methods: A comprehensive review of the literature was conducted by searching MEDLINE from 1966 to April 1997.Results:...

  • Cost-effectiveness of low-molecular-weight heparin in the treatment of proximal deep vein thrombosis. Estrada, Carlos A.; Mansfield, Christopher J.; Heudebert, Gustavo R.; Estrada, C A; Mansfield, C J; Heudebert, G R // JGIM: Journal of General Internal Medicine;Feb2000, Vol. 15 Issue 2, p108 

    Objective: To estimate the cost-effectiveness of low-molecular-weight heparin (LMWH) in the treatment of proximal lower extremity deep venous thrombosis.Design: Cost-effectiveness analysis that includes the treatment of the index case and simulated 3-month...

  • Measured Drug Effect and Cardiovascular Outcomes in Patients Receiving Platelet P2Y12 Receptor Antagonists: Clarifying the Time and Place for Intensive Inhibition. Price, Matthew J. // JAMA: Journal of the American Medical Association;11/7/2012, Vol. 308 Issue 17, p1806 

    The article presents information on effect of P2Y 12antagonists in reducing recurrent cardiovascular events in patient with acute coronary syndromes (ACS). It includes information on platelet function tests that can be used to measure P2Y12 mediated platelet reactivity, thereby providing a...

  • Atenolol use after noncardiac surgery in cardiac patients. Andolsek, Kathryn M. // American Family Physician;5/1/1997, Vol. 55 Issue 6, p2281 

    Presents the randomized, double blind and placebo controlled trial performed by the Mangano and colleagues to evaluate the effect of atenolol on overall survival and cardiovascular morbidity in patients undergoing elective noncardiac surgery. Data and method used in the study; Survival rates of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics